{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:04:57Z","timestamp":1794870297923,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.autrev.2021.102801","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:51:45Z","timestamp":1615683105000},"page":"102801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pediatric inflammatory demyelinating disorders and mimickers: How to differentiate with MRI?"],"prefix":"10.1016","volume":"20","author":[{"given":"Fernanda Veloso","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius de Menezes","family":"Jarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Thiago Souza","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102801_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-0040-1703000","article-title":"Multiple sclerosis in children: current and emerging concepts","volume":"40","author":"Brenton","year":"2020","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00247-019-04582-3","article-title":"Pediatric multiple sclerosis: from clinical basis to imaging spectrum and differential diagnosis","volume":"50","author":"Padilha","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.autrev.2021.102801_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/cen3.12501","article-title":"Magnetic resonance imaging diagnosis of demyelinating diseases: an update","volume":"10","author":"Miki","year":"2019","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.autrev.2021.102801_bb0020","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000259422.44235.a8","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders","volume":"68","author":"Krupp","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0025","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.0000000000002877","article-title":"Consensus definitions for pediatric MS and other demyelinating disorders in childhood","volume":"87","author":"Tardieu","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0035","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/brain\/awp278","article-title":"Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis","volume":"132","author":"Yeh","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2021.102801_bb0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archneurol.2009.135","article-title":"Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults","volume":"66","author":"Waubant","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085741","article-title":"Quantitative determination of regional lesion volume and distribution in children and adults with relapsing- remitting multiple sclerosis","volume":"9","author":"Ghassemi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102801_bb0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1590\/S0004-282X2008000500011","article-title":"Pediatric multiple sclerosis: analysis of clinical and epidemiological aspects according to national MS society consensus 2007","volume":"66","author":"Ferreira","year":"2008","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.autrev.2021.102801_bb0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410330105","article-title":"Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients","volume":"33","author":"Kepes","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0060","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0883073813500713","article-title":"Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children","volume":"29","author":"Yiu","year":"2014","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2003.10.056","article-title":"First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability","volume":"144","author":"Mikaeloff","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.autrev.2021.102801_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s100720170012","article-title":"Pathological abnormalities in the normal-appearing white matter in multiple sclerosis","volume":"22","author":"Allen","year":"2001","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.autrev.2021.102801_bb0075","first-page":"588","volume":"195","author":"Bruck","year":"1996","journal-title":"Macroph. Multiple Scler."},{"key":"10.1016\/j.autrev.2021.102801_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awm291","article-title":"Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection","volume":"131","author":"Zeis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2021.102801_bb0085","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3174\/ajnr.A3581","article-title":"Early white matter changes in childhood multiple sclerosis: a diffusion tensor imaging study","volume":"34","author":"Blaschek","year":"2013","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.autrev.2021.102801_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0145906","article-title":"Alterations in functional and structural connectivity in pediatric-onset multiple sclerosis","volume":"11","author":"Akbar","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102801_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nic.2008.08.002","article-title":"Proton magnetic resonance spectroscopy in multiple sclerosis","volume":"19","author":"Sajja","year":"2009","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.autrev.2021.102801_bb0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jnnp.63.6.736","article-title":"1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis","volume":"63","author":"Davie","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autrev.2021.102801_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2478","article-title":"Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis","volume":"76","author":"Sinnecker","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0110","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2021.102801_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders - an update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2021.102801_bb0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3340\/jkns.2013.53.5.316","article-title":"Neuromyelitis optica mimicking intramedullary tumor","volume":"53","author":"Oh","year":"2013","journal-title":"J. Korean Neurosurg. Soc."},{"key":"10.1016\/j.autrev.2021.102801_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/rg.2018170141","article-title":"Neuromyelitis Optica Spectrum disorders\u202f: Spectrum of MR imaging findings and their differential diagnosis","volume":"38","author":"Dutra","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.autrev.2021.102801_bb0140","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1212\/WNL.0000000000002824","article-title":"Neuromyelitis optica spectrum disorders in children and adolescents","volume":"87","author":"Tenembaum","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.autrev.2015.06.002","article-title":"A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children","volume":"14","author":"Esposito","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2021.102801_bb0150","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S1090-3798(11)70201-X","article-title":"Role of MRI in differentiation of ADEM from MS in children","volume":"15","author":"Sandu","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/RMR.0b013e3182972c03","article-title":"Idiopathic inflammatory demyelinating disorders of the central nervous system in children","volume":"22","author":"Da Rocha","year":"2011","journal-title":"Top. Magn. Reson. Imaging"},{"key":"10.1016\/j.autrev.2021.102801_bb0160","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000338630.20412.45","article-title":"Role of MRI in the differentiation of ADEM from MS in children","volume":"72","author":"Callen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2008.06.004","article-title":"Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases","volume":"200","author":"Franciotta","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.autrev.2021.102801_bb0175","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1590\/S0004-282X1999000500019","article-title":"Magnetic resonance imaging and clinical features in adults with monophasic demyelinating diseases: acute disseminated encephalomyelitis or a variant of multiple sclerosis?","volume":"57","author":"Reis","year":"1999","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.autrev.2021.102801_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1352458508098562","article-title":"Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study","volume":"15","author":"Atzori","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.autrev.2021.102801_bb0185","doi-asserted-by":"crossref","first-page":"E1250","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0190","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Den\u00e8ve","year":"2019","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.autrev.2021.102801_bb0195","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","article-title":"Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease","volume":"87","author":"Lechner","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autrev.2021.102801_bb0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0205","first-page":"1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.autrev.2021.102801_bb0210","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.0000000000000830","article-title":"Distinction between mog antibodypositive and aqp4 antibody-positive nmo spectrum disorders","volume":"83","author":"Mao","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2021.102801_bb0215","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1177\/1352458519837705","article-title":"MOG antibody\u2013associated encephalomyelitis\/encephalitis","volume":"25","author":"Salama","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.autrev.2021.102801_bb0220","first-page":"13","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.autrev.2021.102801_bb0225","first-page":"1","article-title":"Leptomeningeal and intraparenchymal blood barrier disruption in a MOG-IgG-positive patient","volume":"2018","author":"Mohseni","year":"2018","journal-title":"Case Rep. Neurol. Med."},{"key":"10.1016\/j.autrev.2021.102801_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder","volume":"9","author":"dos Passos","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.autrev.2021.102801_bb0235","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2021.102801_bb0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2018.08.009","article-title":"An evolving redefinition of autoimmune encephalitis","volume":"18","author":"Esposito","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2021.102801_bb0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1941875211413135","article-title":"Autoimmune limbic encephalitis with GAD antibodies","volume":"1","author":"Finelli","year":"2011","journal-title":"Neurohosp."},{"key":"10.1016\/j.autrev.2021.102801_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.autrev.2021.102801_bb0255","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.rbr.2016.08.004","article-title":"Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population","volume":"57","author":"Amorim","year":"2017","journal-title":"Rev. Bras Reumatol. (English Ed.)"},{"key":"10.1016\/j.autrev.2021.102801_bb0260","series-title":"Of Child Neurology Devic Disease in a Child With","first-page":"285","author":"Arabshahi","year":"2012"},{"key":"10.1016\/j.autrev.2021.102801_bb0265","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/1744666X.2019.1564040","article-title":"Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus","volume":"15","author":"de Amorim","year":"2019","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.autrev.2021.102801_bb0270","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102801_bb0275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1191\/096120301701548490","article-title":"Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases","volume":"10","author":"T\u00e9llez-Zenteno","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102801_bb0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF01799111","article-title":"Neurological presentations of mitochondrial diseases","volume":"19","author":"Zeviani","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.autrev.2021.102801_bb0285","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mito.2008.05.003","article-title":"Neuroimaging of mitochondrial disease","volume":"8","author":"Saneto","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.autrev.2021.102801_bb0290","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s002340050838","article-title":"MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review","volume":"41","author":"Chu","year":"1999","journal-title":"Neuroradiology"},{"key":"10.1016\/j.autrev.2021.102801_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2004.09.008","article-title":"White matter involvement in mitochondrial diseases","volume":"84","author":"Lerman-Sagie","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.autrev.2021.102801_bb0300","first-page":"369","article-title":"Neuroradiologic findings in children with mitochondrial disorders","volume":"19","author":"Valanne","year":"1998","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.autrev.2021.102801_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1552-6569.2007.00205.x","article-title":"Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters","volume":"18","author":"Da Rocha","year":"2008","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.autrev.2021.102801_bb0310","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WNO.0000000000000621","article-title":"MRI of the optic nerves and chiasm in patients with Leber hereditary optic neuropathy","volume":"38","author":"Blanc","year":"2018","journal-title":"J. Neuro-Ophthalmol."},{"key":"10.1016\/j.autrev.2021.102801_bb0315","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jnnp-2014-308186","article-title":"MRI in Leber\u2019s hereditary optic neuropathy:the relationship to multiple sclerosis","volume":"86","author":"Matthews","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autrev.2021.102801_bb0320","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.52.5.671","article-title":"Magnetic resonance imaging in Leber\u2019s optic neuropathy","volume":"52","author":"Kermode","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autrev.2021.102801_bb0325","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0140-6736(90)93401-A","article-title":"Neurological deterioration in young adults with phenylketonuria","volume":"336","author":"Thompson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102801_bb0330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(94)91281-5","article-title":"Magnetic resonance imaging of the brain in phenylketonuria","volume":"344","author":"Cleary","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102801_bb0335","first-page":"1569","article-title":"Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment","volume":"25","author":"Peng","year":"2004","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.autrev.2021.102801_bb0340","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jmri.21289","article-title":"MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients","volume":"27","author":"Ding","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.autrev.2021.102801_bb0345","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00234-009-0574-z","article-title":"Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria","volume":"51","author":"Manara","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/j.autrev.2021.102801_bb0350","first-page":"1583","article-title":"Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria","volume":"22","author":"Phillips","year":"2001","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.autrev.2021.102801_bb0355","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1148\/rg.2019190016","article-title":"Imaging patterns of toxic and metabolic brain disorders","author":"De Oliveira","year":"2019","journal-title":"RadioGraphics"},{"key":"10.1016\/j.autrev.2021.102801_bb0360","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.autrev.2021.102801_bb0365","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.13712","article-title":"Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent","volume":"58","author":"Hussain","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.autrev.2021.102801_bb0370","first-page":"7","article-title":"Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders","volume":"64","author":"Chang","year":"2003","journal-title":"J. Clin. Psychiatry"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:22:19Z","timestamp":1761600139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1568997221000653"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102801","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric inflammatory demyelinating disorders and mimickers: How to differentiate with MRI?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102801"}}